Enzymes for Food & Beverage Patents: Leaders, Trends & Gaps 2026
- Filing has cooled since its 2018 peak. 142 records that year against 22 in the most recent partial year, with the 2022 midpoint of 111 showing the slide was already underway before the latest reporting lag.
- The top 5 hold 22.7% of the field. 845 of 3,716 records in scope sit with five assignees, but the leader alone accounts for 364 — well ahead of a long tail of smaller filers.
- Baking claims dominate the class map. A21D (baking; doughs) touches 33.7% of records, more than double the next largest class, C12N microorganism and genetic engineering work at 22.9%.
What this landscape covers
This review covers 3,716 patent records published between 2015 and mid-2026 that combine food-enzyme processing terms with claim language on thermal stability, dosage, allergen status, labeling, specificity or side activity. The scope spans baking, brewing and broader food and beverage applications, and captures both the enzyme molecules themselves and the process claims built around them. Filing offices are led by the United States and China, with the EPO, WIPO/PCT, Japan and Canada each carrying a meaningful share of the same underlying inventions.
Publication typically lags filing by around 18 months, so the most recent year in any trend line understates real activity. Family counts, not raw document counts, are used for assignee ranking here, which reduces the effect of continuation filings and multi-jurisdiction duplicates on the concentration figures.
Filing trend and technology composition
Two views of the same 3,716-record dataset: how filing volume has moved year over year, and which IPC subclasses carry the claim density.
A field past its filing peak
Annual filings rose to a peak of 142 in 2018, sat at 111 by the 2022 midpoint, and have declined since — down to 115 in 2017 and 22 in the most recent (partial) year. The trajectory is flat-to-declining rather than growing, even allowing for reporting lag in the final year.
Baking and microbial classes carry the field
A21D (baking; doughs) appears in 33.7% of the 3,716 records in scope, ahead of C12N microorganism and genetic engineering work at 22.9% and A23L foods and non-alcoholic beverages at 16.5%. Adjacent classes — detergents, photolithography, medicinal preparations, semiconductors and coatings — appear at lower but non-trivial shares, reflecting enzyme claims that cross into cleaning, pharma and materials applications. Because records can carry multiple IPC classes, these shares sum to more than the record total by design.
Shares are the percentage of the 3,716 records in scope. A patent can carry several IPC classes, so the shares add up to more than 100%.
Go deeper on Enzymes for Food and Beverage Processing with Eureka
This page is one run against one query. Ask Eureka your own question about enzymes for food and beverage processing and every answer comes back with the patent numbers behind it.
Try EurekaRepresentative filing and most-cited records
Allergen-free compositions (US20130040016A1)
The disclosure covers allergen-free flours, doughs and batters, plus baked products made without eggs or any other major food allergen, achieved by adjusting the relative amounts of components that contribute moisture, alkalinity and texture. The aim is baked products with moistness, springiness, rise, texture and flavor comparable to products made with major allergens present.Filed by Becker, Laura Lane; published 2013-02-14.
| # | Publication no. | Patent title | Citations |
|---|---|---|---|
| 1 | WO2009061380A2 | VARIANTS OF BACILLUS sup. TS-23 ALPHA-AMYLASE WITH ALTERED PROPERTIES | 1,066 |
| 2 | WO1994021785A1 | Enzymes with xylanase activity from aspergillus aculeatus | 778 |
| 3 | WO2013184577A1 | Alpha-amylase variants derived from the alpha amylase of cytophaga SP.amylase|(cspamy2). | 559 |
| 4 | US20070251456A1 | Composite heater and chill plate | 495 |
| 5 | WO2014164777A1 | Alpha-amylase combinatorial variants | 451 |
| 6 | WO2014099523A1 | Alpha-amylase variants | 359 |
| 7 | WO2005042735A1 | Carbohydrate-binding modules of a new family | 326 |
| 8 | WO1995009909A1 | An enzyme preparation comprising a modified enzyme | 291 |
| 9 | WO2013063460A2 | Variant maltohexaose-forming alpha-amylase variants | 270 |
| 10 | US5618751A | Method of making single-step trenches using resist fill and recess | 258 |
Citation counts favour older filings inside any searched corpus — treat them as a signal of influence on downstream work, not of current technical importance.
Each row carries its publication number; clicking a row searches Eureka by that number.
Put your own technology through the same analysis
Eureka on the web
When you want the answer in the next five minutes.
The agent works the prompt against patents and technical literature, citing every source.
Run your analysis now →MCP server & REST API
When it has to run inside your own pipeline.
Patent search, landscape analysis and assignee resolution as MCP tools. Drop them into any agent framework, or call REST directly.
Browse MCP servers →What the numbers say about the field
Three patterns stand out once filing trend, concentration and technology composition are read together.
A leader well ahead of a long tail
The leading assignee holds 364 records on its own, more than four times the tenth-place holder's 33. The top 10 combined reach 28.1% of all records in scope, meaning most of the field sits outside any concentrated group — a long tail of single- or few-filing entrants rather than a handful of dominant players controlling the space.
Filing has cooled from its 2018 high
Volume peaked at 142 in 2018 and had already fallen to 111 by the 2022 midpoint before continuing down to 22 in the latest partial year. Recent-year momentum data shows several of the largest historical filers recording zero filings and a -100% year-over-year change, consistent with a field where core claim space was staked out earlier rather than being actively contested now.
Baking claims anchor the field, microbial claims follow
A21D baking and dough claims appear in a third of all records, well ahead of C12N microorganism and genetic engineering claims at 22.9% and A23L food and beverage claims at 16.5%. Smaller but real overlaps with detergents, medicinal preparations and coatings suggest enzyme chemistry developed here is being repurposed into adjacent industrial and consumer categories.
Eureka can read the same corpus for gaps instead of for coverage: under-claimed branches adjacent to enzymes for food and beverage processing, with the prior art for and against each one.
Who is filing, and where the gaps sit
The ranked field spans 100 companies, but activity is unevenly distributed, and several of the historically largest filers show no recent-year output.
One filer well ahead of the field
The leading assignee's 364 records outpace the fifth-place holder's 82 by more than four to one, and the tenth-place holder sits at just 33. That gap suggests the leader built an early, broad claim base that later entrants have had to file around rather than compete with directly.
Historical leaders have gone quiet
Several of the assignees with the largest historical filing counts show zero filings in the latest year and a -100% year-over-year change. That pattern is consistent with a maturing claim space rather than a shrinking market — the enzymes themselves remain in commercial use, but the patenting activity around them has slowed.
Co-filing is concentrated around one hub
The strongest co-assignee pairs all involve the same leading filer paired with a bakery-technology partner or its own affiliated entities, rather than showing a network of unrelated companies collaborating. This points to internal group filing structures and one close commercial partnership as the main drivers of joint filings, not an open collaborative ecosystem.
| Assignee | Recent year | YoY |
|---|---|---|
| Novozymes A/S | 0 | -100% |
| Danisco US Inc. | 0 | -100% |
| BASF SE | 0 | -100% |
| Puratos NV | 0 | — |
| Novo Nordisk A/S | 0 | — |
| DSM IP Assets B.V. | 0 | — |
| International N&H Denmark ApS | 0 | -100% |
| G.D. Searle & Co. | 0 | — |
Where to take this next
The landscape above frames where filing has concentrated and where it has not. The next step is usually narrower: checking a specific claim, a specific competitor, or a specific white-space branch against live prosecution data.
Check freedom to operate on a specific formulation
Baking and dough claims carry the highest density in this field, which means a new allergen-free or clean-label formulation is more likely to run into existing claims here than in adjacent classes.
Explore this in Eureka →Track a competitor's recent filing pace
Several of the largest historical filers show zero output in the latest year — worth confirming whether that reflects a genuine pull-back or a filing that has not yet published.
Run this check in Eureka →Scope the under-claimed branches before filing
Side-activity minimization and specificity engineering show thinner filing density than the core baking classes, which can mean either open claim space or simply less commercial activity — worth distinguishing before committing.
Investigate in Eureka →Common questions on food and beverage enzyme patents
One assignee leads clearly with 364 records in the ranked field of 100 companies, more than four times the count held by the tenth-place filer at 33. The next four largest filers combined with the leader bring the top 5 to 22.7% of all 3,716 records in scope. Beyond that group, the field spreads into a long tail of companies each holding a much smaller share, so due diligence on any specific enzyme class should not assume the leader's claims are the only ones that matter.
Filing has slowed. Volume peaked at 142 records in 2018, had already fallen to 111 by the 2022 midpoint, and dropped further to 22 in the most recent partial year. Some of that recent decline reflects normal publication lag, since filings typically take about 18 months to appear in the record, but the multi-year downward trend from the 2018 peak predates the most recent lag window and looks like a genuine slowdown rather than a reporting artifact.
The dominant class is A21D, covering baking and doughs, which appears in 33.7% of the 3,716 records in scope. C12N, covering microorganisms and genetic engineering, follows at 22.9%, and A23L, covering foods and non-alcoholic beverages generally, sits at 16.5%. Smaller but real shares also appear in detergent, medicinal-preparation, semiconductor and coatings classes, reflecting enzyme chemistry that crosses from food processing into adjacent industrial and pharmaceutical applications.
Relative to the dense baking and microbial classes, areas like side-activity minimization in enzyme variants, thermal-stability dosing specifically for brewing applications, and specificity engineering for allergen-substitution formulations show thinner filing density in this dataset. Thin filing does not automatically mean open white space — it can also mean lower commercial activity in that sub-area — so any filing decision there should be checked against live prosecution records rather than assumed clear.
Not necessarily. Citation counts inside any searched patent corpus tend to favour older filings simply because they have had more time to be cited by later applications. The most-cited records in this dataset date back to filings from the 1990s and 2000s, which signals influence on how the field developed rather than current commercial dominance. A record with fewer citations but a recent filing date may be more relevant to a present-day freedom-to-operate question.
Research Enzymes for Food and Beverage Processing in depth with Eureka
Go past this page: query the whole enzymes for food and beverage processing corpus yourself, in your own scope.
Every answer comes back with patent numbers you can open.
Disclaimer. This page is generated from Patsnap Eureka data drawn from a limited snapshot of global patent and scientific-literature records, and is provided for general information and reference only.
Patent data carries inherent limitations: recent filings (typically the most recent 18–24 months) are under-counted due to standard publication lag; counts may be reported at either a patent-family or a patent-record basis and are not always directly comparable; classification, applicant-name, and citation data may contain errors, duplicates, or omissions; and the underlying search query defines and constrains the scope shown. As a result, the analysis may be incomplete or inaccurate and may not reflect the full technology landscape.
Nothing on this page constitutes an exhaustive prior-art, novelty, freedom-to-operate, or validity search, nor does it constitute legal, financial, investment, or professional advice, and it should not be relied upon as such. Any patent, commercial, or strategic decision should be verified independently and reviewed with qualified patent, legal, and domain professionals. Patsnap makes no warranties, express or implied, as to the accuracy, completeness, or fitness for any particular purpose of the information presented.
Machine translation. Assignee and organisation names originally recorded in Chinese, Japanese or Korean have been rendered into English by an AI translation step so that the tables stay readable. These renderings are best-effort and may not match a company’s registered English name; the original name is what the underlying patent record carries, and it is what any Eureka query launched from this page uses.